JP5466904B2 - Cleaning method for medical equipment - Google Patents
Cleaning method for medical equipment Download PDFInfo
- Publication number
- JP5466904B2 JP5466904B2 JP2009199783A JP2009199783A JP5466904B2 JP 5466904 B2 JP5466904 B2 JP 5466904B2 JP 2009199783 A JP2009199783 A JP 2009199783A JP 2009199783 A JP2009199783 A JP 2009199783A JP 5466904 B2 JP5466904 B2 JP 5466904B2
- Authority
- JP
- Japan
- Prior art keywords
- biofilm
- salt
- cleaning
- general formula
- medical device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004140 cleaning Methods 0.000 title claims description 27
- 238000000034 method Methods 0.000 title claims description 15
- 239000000203 mixture Substances 0.000 claims description 29
- 150000003839 salts Chemical class 0.000 claims description 28
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000002738 chelating agent Substances 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000012459 cleaning agent Substances 0.000 claims description 4
- 150000001483 arginine derivatives Chemical class 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- -1 bacterial cells Substances 0.000 description 36
- 150000001875 compounds Chemical class 0.000 description 22
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 244000005700 microbiome Species 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 6
- 229960003121 arginine Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000032770 biofilm formation Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- SNRCMWGPCHPRBP-YFKPBYRVSA-N (2s)-2-(hydroxyamino)-3-(1h-imidazol-5-yl)propanoic acid Chemical compound ON[C@H](C(O)=O)CC1=CNC=N1 SNRCMWGPCHPRBP-YFKPBYRVSA-N 0.000 description 1
- DCCWEYXHEXDZQW-BYPYZUCNSA-N (2s)-2-[bis(carboxymethyl)amino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O DCCWEYXHEXDZQW-BYPYZUCNSA-N 0.000 description 1
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 1
- BBBUAWSVILPJLL-UHFFFAOYSA-N 2-(2-ethylhexoxymethyl)oxirane Chemical compound CCCCC(CC)COCC1CO1 BBBUAWSVILPJLL-UHFFFAOYSA-N 0.000 description 1
- OHENVLLVUMQCNT-UHFFFAOYSA-N 2-(aminomethylamino)acetic acid Chemical compound NCNCC(O)=O OHENVLLVUMQCNT-UHFFFAOYSA-N 0.000 description 1
- AKGWUHIOEVNNPC-LURJTMIESA-N Arg-OEt Chemical compound CCOC(=O)[C@@H](N)CCCNC(N)=N AKGWUHIOEVNNPC-LURJTMIESA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000008375 oral care agent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Endoscopes (AREA)
Description
本発明は、バイオフィルム除去剤に関するものであり、より詳細には、微生物が関与するさまざまな分野において、バイオフィルムを効果的に除去し、バイオフィルムに起因する危害を防止するためのバイオフィルム除去剤及びバイオフィルムとその他汚れとの複合汚れを効果的に除去する硬質表面用洗浄剤組成物に関する。 The present invention relates to a biofilm removing agent, and more particularly, biofilm removal for effectively removing biofilm and preventing harm caused by biofilm in various fields involving microorganisms. The present invention relates to a cleaning composition for hard surfaces that effectively removes composite stains of agents and biofilms and other stains.
バイオフィルムは生物膜やスライムとも言われ、一般に水系で微生物が物質の表面に付着・増殖することによって微生物細胞内から多糖やタンパク質などの高分子物質を産生して構造体を形成したものを指す。バイオフィルムが形成すると、微生物を原因とする危害が発生して、様々な産業分野で問題を引き起こす。例えば、食品プラントの配管内にバイオフィルムが形成されると、このバイオフィルムが剥がれ落ち製品内への異物混入につながるだけでなく、微生物由来の毒素で食中毒の原因となる。さらに、金属表面へのバイオフィルム形成は金属腐食の原因となり、設備の老朽化を促進する。
更に、バイオフィルムを形成した微生物集合体に対しては、水系に分散浮遊状態にある微生物と比較して、殺菌剤・静菌剤のような微生物制御薬剤の十分な効果が出せないことも多い。例えば医療の面では近年、内視鏡等の医療機器の狭い隙間や空孔内に微生物が残存してバイオフィルムを形成し、これを原因とする院内感染例が数多く報告されている。ヒト口腔内においては歯に形成するバイオフィルム、いわゆるデンタルプラーク(歯垢)がう食や歯周病の原因となることは良く知られており、これらの問題について長い間検討されている。
A biofilm is also called a biofilm or slime, and generally refers to an aqueous system in which microorganisms adhere to and grow on the surface of substances to produce macromolecular substances such as polysaccharides and proteins from within microbial cells to form structures. . When a biofilm is formed, harm caused by microorganisms occurs, causing problems in various industrial fields. For example, when a biofilm is formed in the piping of a food plant, the biofilm peels off and leads to contamination by foreign substances in the product, and causes food poisoning due to microorganism-derived toxins. Furthermore, biofilm formation on the metal surface causes metal corrosion and promotes aging of the equipment.
Furthermore, compared to microorganisms that are dispersed and suspended in an aqueous system, microbial control agents such as bactericides and bacteriostatic agents are often unable to exert sufficient effects on microbial aggregates that have formed biofilms. . For example, in the medical field, in recent years, there have been many reports of nosocomial infections caused by microorganisms remaining in narrow gaps or holes in medical devices such as endoscopes to form biofilms. In the human oral cavity, it is well known that biofilms formed on teeth, so-called dental plaque (plaque), cause caries and periodontal disease, and these problems have been studied for a long time.
これまでバイオフィルムの危害を防止するためには、微生物、特に細菌に対して殺菌作用もしくは静菌作用を与えることによって菌を増殖させない考え方が一般的に検討されてきた。特許文献1には、アルギニンの塩酸塩、アルギニンエチルエステル、アルギニングルタミン酸などのアルギニンまたはその誘導体と抗菌活性を示す化合物を配合した抗菌製剤が記載されているが、その効果はまだ満足できるものではなく、また、この文献は微生物集合体に対する抗菌効果を示したものであり、バイオフィルムの除去を目的としたものではない。
バイオフィルムを除去する方法として、殺菌剤を用いる方法、キレート剤を用いる方法、酵素を用いる方法などが試みられており、特許文献2では次亜塩素酸塩、アルカリ金属水酸化物と界面活性剤を組み合わせて使用する方法が開示されている。しかしながら、いずれの方法においても効果的にバイオフィルムを除去するには至っておらず、いまだに大きな課題となっている。
すなわち、殺菌性の高いカチオン性界面活性剤や次亜塩素酸塩など即効性の特徴を持つ殺菌性の高い薬剤を用いた場合、系内もしくはバイオフィルム中の有機物により殺菌性は速やかに失われるため、これらは長期間にわたって菌数低減効果を維持することは難しく、殺菌効果が失われると再び菌が増殖する。また、殺菌剤はバイオフィルムを除去するものではないため、微生物が表面に付着しバイオフィルムを形成するまでに作用させなければならない。
前述のようにバイオフィルムは菌体、多糖、タンパク質などいろいろな物質から形成されており、これらの化合物の一部だけを分解することでは、バイオフィルムを完全に除去することは困難であると考えられる。
従って、特許文献3に開示されているような酵素を利用しバイオフィルムを除去する方法においては、ある程度の除去効果は認められるもの完全な除去は困難であるとともに、バイオフィルムの生成抑制効果はないため、残存したバイオフィルム中の菌が再び増殖し、多糖やタンパク質などの高分子物質を産生する。また、バイオフィルムは浴室、台所、厨房、トイレの便器、排水講、排水管などの水分が多く、微生物が増殖しやすい環境で形成されやすいが、各場所において汚れの種類が異なっている。例えば、台所周りでは油脂汚れが、浴室内においては金属石鹸、特に脂肪酸のカルシウム塩が、トイレの便器内では無機質汚れが主となっている。バイオフィルムはこのような汚れと共存し複合汚れとなった場合、通常の界面活性剤を主とした洗浄剤では除去することが困難となり、これら複合汚れを効果的に除去することが望まれている。
Until now, in order to prevent the harm of biofilm, the idea of not allowing bacteria to grow by giving bactericidal or bacteriostatic action to microorganisms, particularly bacteria, has been generally studied. Patent Document 1 describes an antibacterial preparation containing arginine hydrochloride, arginine ethyl ester, arginine glutamic acid or other arginine or a derivative thereof and a compound exhibiting antibacterial activity, but the effect is not yet satisfactory. In addition, this document shows an antibacterial effect on microbial aggregates and is not intended to remove biofilms.
As a method for removing a biofilm, a method using a bactericide, a method using a chelating agent, a method using an enzyme, and the like have been tried. In Patent Document 2, hypochlorite, alkali metal hydroxide and a surfactant are used. A method of using these in combination is disclosed. However, none of the methods has been able to remove the biofilm effectively, and it still remains a big problem.
In other words, when a highly bactericidal agent with immediate effects, such as a highly bactericidal cationic surfactant or hypochlorite, is used, the bactericidal properties are quickly lost due to organic substances in the system or biofilm. Therefore, it is difficult to maintain the effect of reducing the number of bacteria over a long period of time, and when the bactericidal effect is lost, the bacteria grow again. In addition, since the disinfectant does not remove the biofilm, it must act until the microorganisms adhere to the surface and form a biofilm.
As mentioned above, biofilms are formed from various substances such as bacterial cells, polysaccharides and proteins, and it is difficult to completely remove biofilms by decomposing only a part of these compounds. It is done.
Therefore, in the method of removing a biofilm using an enzyme as disclosed in Patent Document 3, although a certain degree of removal effect is recognized, complete removal is difficult and there is no biofilm production suppressing effect. Therefore, the bacteria in the remaining biofilm grow again and produce high-molecular substances such as polysaccharides and proteins. In addition, biofilms are easy to be formed in an environment where microorganisms are likely to multiply, such as bathrooms, kitchens, kitchens, toilet bowls, drainage lectures, drain pipes, etc., but the types of dirt are different in each place. For example, fat and oil stains are mainly used around kitchens, metal soaps in the bathroom, especially fatty acid calcium salts, and inorganic stains in toilet toilets. When biofilm coexists with such dirt and becomes composite dirt, it becomes difficult to remove it with a detergent mainly composed of a normal surfactant, and it is desired to effectively remove these composite dirt. Yes.
従って、本発明の目的は、様々な領域において微生物ならびに微生物産生物質からなるバイオフィルムを効果的に除去するバイオフィルム除去剤及びバイオフィルム除去剤組成物並びにバイオフィルムと各種汚れが共存した複合汚れを効果的に除去する硬質表面用洗浄剤組成物及び医療機器用洗浄剤組成物を提供することにある。 Accordingly, an object of the present invention is to provide a biofilm remover and a biofilm remover composition that effectively remove microorganisms and biofilms composed of microorganisms in various regions, and composite stains in which biofilms and various stains coexist. It is providing the cleaning composition for hard surfaces and the cleaning composition for medical devices which remove effectively.
そこで本発明者は、バイオフィルムを効果的に除去するバイオフィルム除去剤を得るべく鋭意研究を行ったところ、特定のアミノ酸誘導体にバイオフィルムの除去作用があることを見出し本発明を完成するに至った。 Therefore, the present inventor conducted intensive research to obtain a biofilm remover that effectively removes biofilm, and found that a specific amino acid derivative has a biofilm removing action, leading to the completion of the present invention. It was.
すなわち、本発明は、下記一般式(1)
(式中、R1は炭素数4〜18の直鎖又は分岐鎖のアルキル又はアルケニル基を示し、X及びYは次の式
で示される基から選ばれる基を示し、mは1〜5の整数を示す。)
で表わされる塩基性アミノ酸誘導体又はその塩を含有するバイオフィルム除去剤を提供するものである。
That is, the present invention provides the following general formula (1)
(In the formula, R 1 represents a linear or branched alkyl or alkenyl group having 4 to 18 carbon atoms, and X and Y represent the following formulae:
And m represents an integer of 1 to 5. )
A biofilm removing agent containing the basic amino acid derivative represented by the formula (1) or a salt thereof is provided.
また、本発明は、アルギニンまたはその塩とグリシジルエーテルとを反応させて得られるアルギニン誘導体又はその塩を含有するバイオフィルム除去剤を提供するものである。 The present invention also provides a biofilm remover containing an arginine derivative or a salt thereof obtained by reacting arginine or a salt thereof with glycidyl ether.
さらに本発明は、上記のいずれかのバイオフィルム除去剤と、これ以外の界面活性剤及びキレート剤からなる群より選ばれる1種以上とを含有するバイオフィルム除去剤組成物をも提供するものである。 Furthermore, the present invention also provides a biofilm remover composition containing any one of the above biofilm removers and one or more selected from the group consisting of other surfactants and chelating agents. is there.
また、本発明は、上記一般式(1)で表わされる塩基性アミノ酸誘導体若しくはその塩又は上記アルギニン誘導体若しくはその塩を含有する硬質表面用洗浄剤組成物を提供するものである。 Moreover, this invention provides the detergent composition for hard surfaces containing the basic amino acid derivative or its salt represented by the said General formula (1), or the said arginine derivative or its salt.
さらにまた、本発明は、上記一般式(1)で表わされる塩基性アミノ酸誘導体又はその塩と、これ以外の界面活性剤及びキレート剤からなる群より選ばれる1種以上とを含有する硬質表面用洗浄剤組成物を提供するものである。 Furthermore, the present invention is for a hard surface containing the basic amino acid derivative represented by the general formula (1) or a salt thereof, and one or more selected from the group consisting of other surfactants and chelating agents. A cleaning composition is provided.
さらにまた、本発明は、上記一般式(1)で表わされる塩基性アミノ酸誘導体又はその塩を含有する医療機器用洗浄剤組成物を提供するものである。 Furthermore, this invention provides the cleaning composition for medical devices containing the basic amino acid derivative or its salt represented by the said General formula (1).
さらにまた、本発明は、該医療機器用洗浄剤組成物に医療機器を浸漬するか、該水溶液の水流中に医療機器を置くか、又は超音波振動を与えつつ該水溶液と医療機器を接触させる、医療機器の洗浄方法を提供するものである。 Furthermore, the present invention provides a medical device immersed in the cleaning composition for medical devices, placed in a water stream of the aqueous solution, or brought into contact with the medical device while applying ultrasonic vibration. The present invention provides a method for cleaning a medical device.
本発明によれば、様々な領域において微生物ならびに微生物産生物質からなるバイオフィルムを効果的に除去することができ、かつバイオフィルムと各種汚れが共存した複合汚れも効果的に除去することができる。 According to the present invention, biofilms composed of microorganisms and microorganism-producing substances can be effectively removed in various regions, and composite dirt in which biofilms and various kinds of dirt coexist can also be effectively removed.
本発明のバイオフィルム除去剤は、下記一般式(1) The biofilm remover of the present invention has the following general formula (1)
(式中、R1は炭素数4〜18の直鎖又は分岐鎖のアルキル又はアルケニル基を示し、X及びYは次の式 (In the formula, R 1 represents a linear or branched alkyl or alkenyl group having 4 to 18 carbon atoms, and X and Y represent the following formulae:
で示される基から選ばれる基を示し、mは1〜5の整数を示す。)
で表わされる塩基性アミノ酸誘導体又はその塩を1種以上含有する。
And m represents an integer of 1 to 5. )
Containing at least one basic amino acid derivative represented by the formula:
R1で示されるアルキル基又はアルケニル基は、直鎖でも分岐鎖でもよいが、バイオフィルム除去効果の点から炭素数4〜18のものであり、炭素数6〜14のものが好ましく、炭素数8〜14のものがより好ましく、炭素数10〜14のものがさらに好ましい。具体的には、n−へキシル基、2−エチルヘキシル基、n−オクチル基、デシル基、ドデシル基、ミリスチル基等が挙げられる。R1で示されるアルキル基又はアルケニル基は単一あるいは混合であってもよい。また、天然由来、例えばヤシ油やパーム核油由来の混合アルキル組成であってもよい。
一般式(1)中、mは、1〜5の整数を示すが、2〜4が好ましく、さらに3が好ましい。また、Xは−OCH2−CH(−OH)CH2−が好ましく、Yは−NH−C(−NH2)=NHが好ましい。
塩基性アミノ酸誘導体(1)の塩としては、塩酸塩、硫酸塩、リン酸塩などの無機酸の塩、酢酸塩、乳酸塩、クエン酸塩、酸性アミノ酸塩などの有機酸の塩が挙げられ、好ましいものとしては、塩酸塩、酢酸塩、乳酸塩、クエン酸塩が挙げられる。
The alkyl group or alkenyl group represented by R 1 may be linear or branched, but has 4 to 18 carbon atoms, preferably 6 to 14 carbon atoms from the viewpoint of the effect of removing a biofilm. Those having 8 to 14 are more preferable, and those having 10 to 14 carbon atoms are more preferable. Specific examples include an n-hexyl group, a 2-ethylhexyl group, an n-octyl group, a decyl group, a dodecyl group, and a myristyl group. The alkyl group or alkenyl group represented by R 1 may be single or mixed. Moreover, the mixed alkyl composition derived from natural origin, for example, palm oil or palm kernel oil, may be sufficient.
In general formula (1), m represents an integer of 1 to 5, preferably 2 to 4, and more preferably 3. X is preferably —OCH 2 —CH (—OH) CH 2 —, and Y is preferably —NH—C (—NH 2 ) ═NH.
Examples of the salt of the basic amino acid derivative (1) include salts of inorganic acids such as hydrochloride, sulfate and phosphate, and salts of organic acids such as acetate, lactate, citrate and acidic amino acid salt. Preferable examples include hydrochloride, acetate, lactate and citrate.
一般式(1)で表される化合物は、塩基性アミノ酸、例えばアルギニン、リジン、オルチニン、ヒスチジン、ヒドロキシヒスチジン等とグリシジルエーテル、脂肪酸クロライド、脂肪酸無水物、エポキシアルカンなどの化合物とを反応させることにより得られる。好ましいものとしては、アルギニンとグリシジルエーテル、脂肪酸クロライド、酸無水物、エポキシアルカンなどの化合物とを反応させることにより得られる化合物で、さらに好ましくはアルギニンとグリシジルエーテルとの反応により得られる、下記一般式(2)の化合物である。 The compound represented by the general formula (1) is obtained by reacting a basic amino acid such as arginine, lysine, ortinine, histidine, hydroxyhistidine and the like with a compound such as glycidyl ether, fatty acid chloride, fatty acid anhydride, or epoxyalkane. can get. Preferred is a compound obtained by reacting arginine with a compound such as glycidyl ether, fatty acid chloride, acid anhydride, or epoxyalkane, and more preferably obtained by reacting arginine with glycidyl ether. It is a compound of (2).
(R2は、炭素数4〜18の直鎖または分岐鎖のアルキルまたはアルケニル基を示す。)
これら反応生成物はバイフィルム除去性能を阻害しない範囲で未反応物、副生成物を含んでいてもよい。
(R 2 represents a linear or branched alkyl or alkenyl group having 4 to 18 carbon atoms.)
These reaction products may contain unreacted products and by-products as long as the bifilm removal performance is not impaired.
なお、特開平9−271655号公報にグリシジルエーテルと塩基性アミノ酸またはその塩とを反応させて得られる塩基性アミノ酸誘導体またはその塩を含有する化粧料及び洗浄剤組成物が開示されているが、これは、皮膚及び粘膜に対して低刺激であり、毛髪等に対するコンディショニング効果を向上させる目的で用いられており、本発明の効果、すなわちバイオフィルム除去効果やバイオフィルムと各種汚れが共存した複合汚れの除去効果を何ら予見、推測しうるものではない。 JP-A-9-271655 discloses a cosmetic and a detergent composition containing a basic amino acid derivative or a salt thereof obtained by reacting glycidyl ether with a basic amino acid or a salt thereof. It is hypoallergenic to the skin and mucous membranes, and is used for the purpose of improving the conditioning effect on hair and the like. It is impossible to foresee or infer any removal effect.
本発明のバイオフィルム除去剤の使用量は用途、剤型により適宜決定することができるが、バイオフィルムへ作用させる場面においては、通常、水溶液の状態で用いられ、その濃度としてはコストと取り扱い性とバイオフィルム除去性能の面から一般式(1)の化合物濃度として0.001〜10重量%が好ましく、より好ましくは0.002〜7重量%、さらに好ましくは0.005〜5重量%の範囲である。 The use amount of the biofilm remover of the present invention can be appropriately determined depending on the application and dosage form, but is usually used in the form of an aqueous solution in the case of acting on the biofilm, and its concentration is cost and handleability. In terms of biofilm removal performance, the concentration of the compound of the general formula (1) is preferably 0.001 to 10% by weight, more preferably 0.002 to 7% by weight, and still more preferably 0.005 to 5% by weight. It is.
本発明のバイオフィルム除去剤は、バイオフィルムを形成した面に水溶液を接触させることにより効果を発揮し、その方法としては浸漬、塗布あるいは散布するなどがある。さらに、スポンジ、タオル、ブラシ、水流などの物理力を加えてもよい。また、バイオフィルム除去剤を作用させておく時間は、付着しているバイオフィルムの量、バイオフィルム除去剤を作用させる濃度、作用温度、物理力の有無により異なるが、通常は数秒から数時間の範囲である。また、作用後は流水などにより、除去されたバイオフィルムを速やかにすすぎ流すことが望ましい。 The biofilm remover of the present invention exhibits an effect by bringing an aqueous solution into contact with the surface on which the biofilm is formed. Examples of the method include dipping, coating, or spraying. Further, physical force such as sponge, towel, brush, water flow, etc. may be applied. In addition, the time for which the biofilm remover is allowed to act varies depending on the amount of biofilm that is attached, the concentration at which the biofilm remover acts, the temperature of action, and the presence or absence of physical force, but it usually ranges from a few seconds to several hours. It is a range. In addition, it is desirable that the removed biofilm is immediately rinsed away with running water after the action.
本発明のバイオフィルム除去剤組成物及び硬質表面用洗浄剤組成物は、一般式(1)で表される化合物の溶解性を高める、あるいはバイオフィルム除去性能を向上させる、さらには洗浄効果を高める目的で、一般式(1)で表される化合物以外の陰イオン界面活性剤、非イオン界面活性剤、両性界面活性剤、陽イオン界面活性剤から選ばれる1種以上を併用することができる。 The biofilm remover composition and the hard surface cleaner composition of the present invention enhance the solubility of the compound represented by the general formula (1), improve the biofilm removal performance, and further enhance the cleaning effect. For the purpose, one or more selected from anionic surfactants, nonionic surfactants, amphoteric surfactants and cationic surfactants other than the compound represented by the general formula (1) can be used in combination.
陰イオン性界面活性剤としては、リグニンスルホン酸塩、アルキルベンゼンスルホン酸塩、アルキルスルホン酸塩、ポリオキシエチレン(以下、POEと記す)アルキルスルホン酸塩、POEアルキルフェニルエーテルスルホン酸塩、POEアルキルフェニルエーテルリン酸エステル塩、POEアリールフェニルエーテルスルホン酸塩、アルキル硫酸エステル塩、POEアルキルエーテル硫酸エステル塩、POEアリールフェニルエーテルリン酸エステル塩、ナフタレンスルホン酸塩、ナフタレンスルホン酸ホルマリン縮合物、POEトリベンジルフェニルエーテルスルホン酸塩、アルキルリン酸塩、POEアルキルリン酸塩、POEトリベンジルフェニルエーテルリン酸エステル塩、ジアルキルスルホコハク酸塩、脂肪酸塩(石けん)、POEアルキルエーテル酢酸塩等が挙げられ、中でもアルキル硫酸エステル塩やPOEアルキルエーテル硫酸エステル塩又はPOEアルキルエーテル酢酸塩を用いることがより好ましい。 Examples of the anionic surfactant include lignin sulfonate, alkylbenzene sulfonate, alkyl sulfonate, polyoxyethylene (hereinafter referred to as POE) alkyl sulfonate, POE alkylphenyl ether sulfonate, and POE alkylphenyl. Ether phosphate ester salt, POE aryl phenyl ether sulfonate, alkyl sulfate ester salt, POE alkyl ether sulfate ester salt, POE aryl phenyl ether phosphate ester salt, naphthalene sulfonate, naphthalene sulfonate formalin condensate, POE tribenzyl Phenyl ether sulfonate, alkyl phosphate, POE alkyl phosphate, POE tribenzyl phenyl ether phosphate ester salt, dialkyl sulfosuccinate, fatty acid salt (soap), P E alkyl ether acetate and the like, it is more preferable to use inter alia alkyl sulfate and POE alkyl ether sulfate or POE alkyl ether acetates.
非イオン性界面活性剤としては、POEアルキルエーテル、POEアルキルフェニルエーテル、ポリオキシプロピレン・POE(ブロック又はランダム)アルキルエーテル、POEアリールフェニルエーテル、POEスチレン化フェニルエーテル、POEトリベンジルフェニルエーテル等の1価アルコール誘導体型非イオン性界面活性剤、(ポリ)グリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、POEソルビタン脂肪酸エステル、アルキルポリグリコシド、脂肪酸アルカノールアミド等の多価アルコール誘導体型非イオン性界面活性剤等が挙げられ、中でもPOEアルキルエーテル、(ポリ)グリセリン脂肪酸エステル、アルキルポリグリコシド、ソルビタン脂肪酸エステル又はPOEソルビタン脂肪酸エステルを用いることがより好ましい。 Nonionic surfactants include POE alkyl ether, POE alkyl phenyl ether, polyoxypropylene / POE (block or random) alkyl ether, POE aryl phenyl ether, POE styrenated phenyl ether, POE tribenzyl phenyl ether, etc. Polyhydric alcohol derivative type nonionic surfactant such as polyhydric alcohol derivative type nonionic surfactant, (poly) glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, POE sorbitan fatty acid ester, alkyl polyglycoside, fatty acid alkanolamide, etc. Activating agents, etc., among which POE alkyl ether, (poly) glycerin fatty acid ester, alkyl polyglycoside, sorbitan fatty acid ester or POE sorbitan fatty acid ester It is more preferable to use the ether.
両性界面活性剤としては、アルキルカルボキシベタイン、アルキルスルホベタイン、アルキルヒドロキシスルホベタイン、脂肪酸アミドベタイン、アルキルジメチルアミンオキサイド等が挙げられ、中でもアルキルジメチルアミンオキサイド、アルキルヒドロキシスルホベタインを用いることが好ましい。 Examples of amphoteric surfactants include alkylcarboxybetaines, alkylsulfobetaines, alkylhydroxysulfobetaines, fatty acid amide betaines, and alkyldimethylamine oxides. Among them, alkyldimethylamine oxides and alkylhydroxysulfobetaines are preferably used.
陽イオン界面活性剤としては、アルキルトリメチルアンモニウム塩、ジアルキルジメチルアンモニウム塩等が挙げられ、中でもアルキルトリメチルアンモニウム塩が好ましい。前記塩としては、ハロゲン化物が好ましく、塩化物、臭化物がより好ましい。 Examples of the cationic surfactant include alkyltrimethylammonium salts and dialkyldimethylammonium salts. Among them, alkyltrimethylammonium salts are preferable. As said salt, a halide is preferable and a chloride and a bromide are more preferable.
これらの界面活性剤のうち、非イオン性界面活性剤が好ましい。また、これらの界面活性剤は一般式(1)の化合物と目的に応じて任意の割合で併用することができる。好ましい割合は、製品の安定性と洗浄効果の点で、重量比で、一般式(1)の化合物:他の界面活性剤=1:99〜99:1であり、より好ましくは、5:95〜95:5であり、更に好ましくは、10:90〜80:20である。 Of these surfactants, nonionic surfactants are preferred. Further, these surfactants can be used in combination at any ratio depending on the purpose and the compound of the general formula (1). A preferred ratio is a compound of the general formula (1): other surfactants = 1: 99 to 99: 1 in terms of weight ratio in terms of product stability and cleaning effect, and more preferably 5:95. It is -95: 5, More preferably, it is 10: 90-80: 20.
本発明のバイオフィルム除去剤及び硬質表面用洗浄剤組成物はその効果を高める目的で、キレート剤を併用することができる。キレート剤としては、ニトリロトリ酢酸、エチレンジアミン四酢酸、イミノジコハク酸、アスパラギン酸ジ酢酸、アミノメチルグリシンジ酢酸などのアミノカルボン酸誘導体及び/又はそれらの塩、クエン酸、酒石酸、グルコン酸など有機酸の塩、ポリアクリル酸及び/又はその塩、ポリアクリル酸/マレイン酸共重合体及び/又はその塩などの高分子電解質系化合物、トリポリリン酸塩、オルトリン酸塩、ピロリン酸塩などのリン酸系化合物、1−ヒドロキシエタン−1,1−ジホスホン酸及び/又はその塩、アミノトリ(メチレンホスホン酸)及び/又はその塩、エチレンジアミンテトラ(メチレンホスホン酸)及び/又はその塩などのホスホン酸系化合物、A型ゼオライト、B型ゼオライトなどのアルミノケイ酸などが挙げられ、中でもニトリロトリ酢酸塩、エチレンジアミン四酢酸塩、トリポリリン酸塩、1−ヒドロキシエタン−1,1−ジホスホン酸及び/又はその塩が好ましい。
また、これらのキレート剤は一般式(1)の化合物と目的に応じて任意の割合で併用することができる。好ましい割合は、洗浄効果の点で、重量比で、一般式(1)の化合物:キレート剤=1:99〜99:1であり、更に好ましくは、5:95〜95:5である。
The biofilm remover and hard surface cleaner composition of the present invention can be used in combination with a chelating agent for the purpose of enhancing the effect. Chelating agents include aminocarboxylic acid derivatives such as nitrilotriacetic acid, ethylenediaminetetraacetic acid, iminodisuccinic acid, aspartic acid diacetic acid, aminomethylglycine diacetic acid and / or their salts, organic acid salts such as citric acid, tartaric acid and gluconic acid Polyacrylic acid and / or salt thereof, polyelectrolyte compound such as polyacrylic acid / maleic acid copolymer and / or salt thereof, phosphoric acid compound such as tripolyphosphate, orthophosphate, pyrophosphate, Phosphonic acid compounds such as 1-hydroxyethane-1,1-diphosphonic acid and / or salt thereof, aminotri (methylenephosphonic acid) and / or salt thereof, ethylenediaminetetra (methylenephosphonic acid) and / or salt thereof, type A Examples include aluminosilicates such as zeolite and B-type zeolite. Nitrilotriacetic acid salts, salts of ethylenediaminetetraacetic acid, tripolyphosphates, 1-hydroxyethane-1,1-diphosphonic acid and / or its salts are preferred.
Further, these chelating agents can be used in combination with the compound of the general formula (1) at an arbitrary ratio depending on the purpose. A preferred ratio is, in terms of washing effect, a weight ratio of the compound of the general formula (1): chelating agent = 1: 99 to 99: 1, and more preferably 5:95 to 95: 5.
本発明のバイオフィルム除去剤組成物及び硬質表面用洗浄剤組成物の製品形態中の一般式(1)の化合物の濃度としては、用途、剤型により適宜決定することができるが、製品化難易度と効果の観点から、0.001〜80重量%が好ましく、さらに0.002〜60重量%が好ましく、よりさらに0.005〜40重量%の範囲が好ましい。 The concentration of the compound of the general formula (1) in the product form of the biofilm remover composition and the hard surface cleaning composition of the present invention can be appropriately determined depending on the use and dosage form, but is difficult to commercialize. From the viewpoint of degree and effect, 0.001 to 80% by weight is preferable, 0.002 to 60% by weight is more preferable, and 0.005 to 40% by weight is more preferable.
本発明のバイオフィルム除去剤、バイオフィルム除去剤組成物及び硬質表面用洗浄剤組成物の剤型としては、用途、目的に応じて、水、エタノール、イソプロパノールなどの溶剤に溶かした溶液、あるいは固体、ゲル状、乳化・分散状、粉末状、エアゾールなどが挙げられ、これらから適宜選択することができ、作用濃度に合わせた製品形態はもちろんのこと、高濃度の製品形態にしておき、使用場面において希釈する、あるいは使用場面において一般式(1)の化合物と界面活性剤及び又はキレート剤を配合し使用することも可能である。 The dosage form of the biofilm remover, biofilm remover composition, and hard surface cleaner composition of the present invention includes a solution dissolved in a solvent such as water, ethanol, isopropanol, or a solid depending on the purpose and purpose. , Gel, emulsified / dispersed, powder, aerosol, etc., and can be selected as appropriate. It is also possible to dilute or use the compound of the general formula (1) and a surfactant and / or a chelating agent in the usage scene.
本発明のバイオフィルム除去剤は、本発明の目的を損なわない範囲で、増粘剤、粘度調整剤、pH調整剤、溶剤、香料、着色剤、酸化防止剤、防腐剤、蛍光剤、賦形剤、ソイルリリース剤、漂白剤、漂白活性化剤、粉末化剤、造粒剤、コーティング剤などを配合することができる。 The biofilm remover of the present invention is a thickener, a viscosity modifier, a pH adjuster, a solvent, a fragrance, a colorant, an antioxidant, an antiseptic, a fluorescent agent, and an excipient as long as the object of the present invention is not impaired. Agents, soil release agents, bleaching agents, bleach activators, powdering agents, granulating agents, coating agents and the like can be blended.
本発明品はバイオフィルムの危害が懸念される広い分野に使用することが可能である。例えば菌汚染リスクの高い食品製造又は飲料製造プラント用洗浄剤、台所、厨房、浴室、トイレの便器、キッチン又は厨房などの排水溝、排水管に応用できる。また、産業用の冷却タワーなどの冷却水系、脱塩装置、パルプ及び紙製造系や浴槽、プール、人工池などの循環水系路に応用できる。バイオフィルムが形成しやすい医療機器、例えば内視鏡やカテーテル、人工透析機等の洗浄剤にも応用できる。更に、高い安全性を有することから、身体を対象とした洗浄剤、歯磨き剤、口腔ケア剤、入れ歯ケア剤、コンタクトレンズ洗浄剤などに使用することも可能である。 The product of the present invention can be used in a wide range of fields where biofilms are a concern. For example, the present invention can be applied to cleaning agents for food production or beverage production plants with a high risk of bacterial contamination, kitchens, kitchens, bathrooms, toilet bowls, drains for kitchens or kitchens, and drain pipes. It can also be applied to cooling water systems such as industrial cooling towers, desalination equipment, pulp and paper manufacturing systems, and circulating water systems such as bathtubs, pools, and artificial ponds. The present invention can also be applied to medical devices in which biofilms are easily formed, for example, cleaning agents such as endoscopes, catheters, and artificial dialysis machines. Furthermore, since it has high safety, it can be used for cleaning agents for the body, dentifrices, oral care agents, denture care agents, contact lens cleaners, and the like.
本発明の医療機器用洗浄剤組成物は、上記一般式(1)で表わされる塩基性アミノ酸誘導体又はその塩を含有するものである。
ここで、医療機器としては、内視鏡、カテーテル、人工透析機(特に人工透析液の回路)等の体液が付着する可能性の高い医療機器が挙げられる。ここで内視鏡としては、喉頭内視鏡、気管支鏡、上部消化器内視鏡、小腸内視鏡、大腸内視鏡、胸腔鏡、腹腔鏡、膀胱鏡、胆道鏡、間接鏡、血管内視鏡等が挙げられる。
近年、これらの内視鏡の応用分野は拡大しており、本発明の洗浄剤組成物は、これらの内視鏡洗浄用として特に有用である。
The medical device cleaning composition of the present invention contains the basic amino acid derivative represented by the above general formula (1) or a salt thereof.
Here, examples of the medical device include medical devices with a high possibility of attachment of body fluids such as an endoscope, a catheter, and an artificial dialysis machine (particularly, an artificial dialysis fluid circuit). Endoscopes here include laryngoscope, bronchoscope, upper gastrointestinal endoscope, small intestine endoscope, large intestine endoscope, thoracoscope, laparoscope, cystoscope, biliary scope, indirect mirror, intravascular An endoscope etc. are mentioned.
In recent years, the application field of these endoscopes has expanded, and the cleaning composition of the present invention is particularly useful for cleaning these endoscopes.
医療機器用洗浄剤組成物の使用方法としては、該医療機器用洗浄剤組成物に医療機器を浸漬するか、該水溶液の水流中に医療機器を置くか、又は超音波振動を与えつつ該水溶液と医療機器を接触させる、等の方法が挙げられる。該医療機器用洗浄剤組成物を希釈して使用する場合0.2〜20%、特に、0.3〜15重量%、更に0.4〜12重量%の水溶液が好ましい。 The medical device cleaning composition may be used by immersing the medical device in the medical device cleaning composition, placing the medical device in a water stream of the aqueous solution, or applying ultrasonic vibration to the aqueous solution. And a medical device are brought into contact with each other. When the medical device cleaning composition is diluted and used, an aqueous solution of 0.2 to 20%, particularly 0.3 to 15% by weight, and more preferably 0.4 to 12% by weight is preferable.
製造例1
N−[2−ヒドロキシ−3−(2−エチルヘキシル)オキシプロピル]−L−アルギニン塩酸塩の製造
還流冷却管、滴下ロート、温度計及び撹拌羽根を備えた200mLの四つ口フラスコに、L(+)−アルギニン9.4g(53.7mmol)、水50.0g、エタノール50.0gを入れ、窒素雰囲気下、撹拌を行いながら78℃に昇温した。次に、反応系内を78〜80℃に保ち、2−エチルヘキシルグリシジルエーテル10.0g(53.7mmol)を滴下した。その後、78〜80℃で4時間熟成を行った後、室温に戻した。次に、6mol/Lの塩酸水溶液9.8g(53.7mmol)を添加し、中和を行った。反応溶液から減圧で水とエタノールを完全に留去し、N−[2−ヒドロキシ−3−(2−エチルヘキシル)オキシプロピル]−L−アルギニン塩酸塩の白色固体21.6g得た。この化合物は、表1の化合物2に相当する。
同様の方法で、C10(イソデシル)、C12(直鎖)を有する化合物を製造した。これらの化合物は、それぞれ表1の化合物3、化合物4に相当する。
Production Example 1
Production of N- [2-hydroxy-3- (2-ethylhexyl) oxypropyl] -L-arginine hydrochloride Into a 200 mL four-necked flask equipped with a reflux condenser, a dropping funnel, a thermometer and a stirring blade was added L ( (+)-Arginine (9.4 g, 53.7 mmol), water (50.0 g), and ethanol (50.0 g) were added, and the mixture was heated to 78 ° C. with stirring in a nitrogen atmosphere. Next, 10.0 g (53.7 mmol) of 2-ethylhexyl glycidyl ether was added dropwise while maintaining the reaction system at 78 to 80 ° C. Then, after aging at 78-80 ° C. for 4 hours, the temperature was returned to room temperature. Next, 9.8 g (53.7 mmol) of 6 mol / L hydrochloric acid aqueous solution was added for neutralization. Water and ethanol were completely distilled off from the reaction solution under reduced pressure to obtain 21.6 g of a white solid of N- [2-hydroxy-3- (2-ethylhexyl) oxypropyl] -L-arginine hydrochloride. This compound corresponds to Compound 2 in Table 1.
In the same manner, compounds having C10 (isodecyl) and C12 (straight chain) were produced. These compounds correspond to the compounds 3 and 4 in Table 1, respectively.
実施例1
<バイオフィルム除去能の検定>
緑膿菌(Pseudomonas aeruginosa NBRC13275)、セラチア菌(Serratia marcescens NBRC12648)、表皮ブドウ球菌(Klebsiella pneumoniae ATCC13883)をそれぞれ大豆−カゼインダイジェストアガー(Soybean-Casein Digest Agar)〔SCD寒天培地:日本製薬(株)製〕を用いて、37℃、24時間の前培養してコロニー形成したものから極少量の菌塊を、滅菌済みの竹串を用いて、ミューラーヒントン培地を各1.5mL注加した24ウェルマイクロプレート内に接種した。これを37℃、24時間培養後に培養液を廃棄し、精製水2mLで各ウェルを5回リンスし、マイクロプレート壁にバイオフィルムを形成、付着させた。ただちに、表2及び3に示す調製したバイオフィルム除去剤を含む配合品(本発明品1〜24及び対照としての比較品1〜19)を2mL注加し、室温で10分間作用させた後、各ウェル中のバイオフィルム制御剤を廃棄した。精製水2mLで各ウェルを2回リンスした後、0.1%クリスタルバイオレット2mLを注加し、マイクロプレート壁に残存するバイオフィルムを染色した。余分な染色液を水でリンス後に80%エタノール2mLを注加し、バイオフィルムを染色したクリスタルバイオレットを均一に溶解後、570nmで吸光度を測定し測定値とした。同様にバイオフィルム除去剤を作用させていないウェルについて0.1%クリスタルバイオレットで処理後、吸光度を測定し初期値とした。また、24ウェル中にミューラーヒントン培地を各1.5mLはするが菌塊を接種しないものを同様に行い、吸光度を測定してブランク値とした。各試験は5回行い平均した値を用いた。除去率は下記の式にて算出した。表中の濃度は全量に対する有効分濃度(重量%)で示し、また、pHは必要に応じて水酸化カリウムあるいは塩酸を用いて調整した。
Example 1
<Biofilm removal ability test>
Pseudomonas aeruginosa NBRC13275, Serratia marcescens NBRC12648, and Staphylococcus epidermidis Klebsiella pneumoniae ATCC13883 (Soybean-Casein Digest Agar) [SCD agar medium: manufactured by Nippon Pharmaceutical Co., Ltd.] ], A very small amount of bacterial mass from a colony formed by pre-culturing at 37 ° C. for 24 hours, and using a sterilized bamboo skewer, 1.5 mL each of Mueller Hinton medium was added to each well. Inoculated into plates. After culturing at 37 ° C. for 24 hours, the culture solution was discarded, and each well was rinsed 5 times with 2 mL of purified water to form and attach a biofilm to the microplate wall. Immediately after adding 2 mL of the compounded product containing the prepared biofilm remover shown in Tables 2 and 3 (present products 1 to 24 and comparative products 1 to 19 as a control) and allowing them to act at room temperature for 10 minutes, The biofilm control agent in each well was discarded. Each well was rinsed twice with 2 mL of purified water, and then 2 mL of 0.1% crystal violet was added to stain the biofilm remaining on the microplate wall. After rinsing the excess staining solution with water, 2 mL of 80% ethanol was added, and the crystal violet stained biofilm was uniformly dissolved, and then the absorbance was measured at 570 nm to obtain a measured value. Similarly, after the well not treated with the biofilm remover was treated with 0.1% crystal violet, the absorbance was measured to obtain an initial value. In addition, 1.5 mL each of Mueller Hinton medium in 24 wells but not inoculated with the bacterial mass was performed in the same manner, and the absorbance was measured to obtain a blank value. Each test was performed five times and the average value was used. The removal rate was calculated by the following formula. Concentrations in the table are shown as effective concentration (% by weight) based on the total amount, and pH was adjusted using potassium hydroxide or hydrochloric acid as necessary.
除去率(%)=100×[{(初期値−ブランク値)−(測定値−ブランク値)}/(初期値−ブランク値)] Removal rate (%) = 100 × [{(initial value−blank value) − (measured value−blank value)} / (initial value−blank value)]
得られたバイオフィルム除去率を表2及び3に示した。
なお、表中の化合物1〜5は次の表1に示すものである。
The obtained biofilm removal rates are shown in Tables 2 and 3.
In addition, the compounds 1-5 in a table | surface are shown in following Table 1.
以上の結果より、本発明のバイオフィルム除去剤を用いることによりバイオフィルムを良好に除去できることがわかる。 From the above results, it can be seen that the biofilm can be satisfactorily removed by using the biofilm remover of the present invention.
実施例2
<風呂汚れに対する洗浄試験>
4人家族の家庭の風呂の排水溝に縦80mm×横20mm×厚さ1mmのポリプロピレン製のテストピースを設置し、2ヶ月放置後に取り出し試験片とし、洗浄力を以下のように評価した。表3に示す洗浄剤組成物(本発明品10〜24及び対照としての比較品10〜19)を3mL含ませたテストピースと同じ大きさの木綿布を、試験片に5分間密着させた後、スポンジでこすった後の汚れの状態を視覚によって下記の5段階で評価し、5回の平均値である風呂汚れに対する洗浄性の結果を表3に示した。
5: 汚れ落ちが非常に良好
4: 汚れ落ちが良好
3: 汚れ落ちにムラがある
2: 若干汚れが落ちる程度
1: ほとんど汚れが落ちない
Example 2
<Cleaning test for bath dirt>
A test piece made of polypropylene having a length of 80 mm, a width of 20 mm, and a thickness of 1 mm was installed in the drainage groove of a bath of a family of four. The test piece was taken out after being left for 2 months, and the cleaning power was evaluated as follows. After a cotton cloth of the same size as the test piece containing 3 mL of the cleaning composition shown in Table 3 (the present invention products 10-24 and the comparative products 10-19 as a control) was adhered to the test piece for 5 minutes The state of the soil after rubbing with a sponge was visually evaluated in the following five stages, and the results of the detergency against bath soil, which is an average of 5 times, are shown in Table 3.
5: Very good dirt removal 4: Good dirt removal 3: Unevenness in dirt removal 2: Slight dirt removal degree 1: Almost no dirt removal
実施例3
<台所汚れに対する洗浄試験>
4人家族の家庭の台所の排水溝に縦80mm×横20mm×厚さ1mmのステンレス製のテストピースを設置し、2ヶ月放置後に取り出し試験片とし、洗浄力を以下のように評価した。表3に示す洗浄剤組成物(本発明品10〜24及び対照としての比較品10〜19)を3mL含ませたテストピースと同じ大きさの木綿布を、試験片に5分間密着させた後、スポンジでこすった後の汚れの状態を視覚によって下記の5段階で評価し、5回の平均値である台所汚れに対する洗浄性の結果を表3に示した。
5: 汚れ落ちが非常に良好
4: 汚れ落ちが良好
3: 汚れ落ちにムラがある
2: 若干汚れが落ちる程度
1: ほとんど汚れが落ちない
Example 3
<Cleaning test for kitchen dirt>
A test piece made of stainless steel 80 mm long × 20 mm wide × 1 mm thick was placed in a drainage ditch of a family of four people's family, left as it was for 2 months, and used as a test piece. The detergency was evaluated as follows. After a cotton cloth of the same size as the test piece containing 3 mL of the cleaning composition shown in Table 3 (the present invention products 10-24 and the comparative products 10-19 as a control) was adhered to the test piece for 5 minutes The state of the soil after rubbing with a sponge was visually evaluated in the following five levels. Table 3 shows the results of washing performance against kitchen soil, which is an average of 5 times.
5: Very good dirt removal 4: Good dirt removal 3: Unevenness in dirt removal 2: Slight dirt removal degree 1: Almost no dirt removal
実施例4:テフロン(登録商標)チューブでのバイオフィルム除去試験
緑膿菌(Pseudomonas aeruginosa NBRC13275)およびクレブシェラ菌(Klebsiella pneumoniae ATCC13883)を大豆−カゼインダイジェストアガー(Soybean-Casein Digest Agar)〔SCD寒天培地:日本製薬(株)製〕を用いて37℃24時間の前培養を行った。
得られた寒天培地上の細菌コロニーを1白金耳接種し、コール−パーマーインストルメント(株)(Cole-Parmer Instrument Company)製のマスターフレックス(Masterflex)定量ポンプシステム(システムモデルNo.7553−80、ヘッドNo.7016−21)を用い、テフロン(登録商標)製チューブ(内径5mm、外径7mm)に細菌を懸濁させた培養液を流量50〜60mL/分として30℃で48時間循環させ、テフロン(登録商標)チューブ内表面にバイオフィルムを形成させた。培養液を廃棄し、表2に示した組成物を滅菌精製水で10%濃度に調製した。この液を流量50〜60mL/分として30℃で循環させ、処理前及び処理30分後にテフロン(登録商標)チューブ内に付着したバイオフィルムを0.1%クリスタルバイオレットで染色処理後、目視で確認した。バイオフィルム形成状態は、コントロールのバイオフィルム付着量の0〜10%を◎、10〜40%を○、40〜80%を△、80%以上を×とした。
結果を表4に示す。
Example 4: Biofilm removal test in a Teflon (registered trademark) tube Pseudomonas aeruginosa NBRC13275 and Klebsiella pneumoniae ATCC13883 (Soybean-Casein Digest Agar) [SCD agar medium: Nippon Pharma Co., Ltd.] was used for pre-culture at 37 ° C. for 24 hours.
One platinum colony of the obtained bacterial colonies on the agar medium was inoculated, and the Masterflex metering pump system (system model No. 7553-80, manufactured by Cole-Parmer Instrument Company), Head No. 7016-21) was used to circulate a culture solution in which bacteria were suspended in a Teflon (registered trademark) tube (inner diameter 5 mm, outer diameter 7 mm) at a flow rate of 50 to 60 mL / min at 30 ° C. for 48 hours, A biofilm was formed on the inner surface of the Teflon (registered trademark) tube. The culture solution was discarded, and the composition shown in Table 2 was prepared to a concentration of 10% with sterilized purified water. This liquid is circulated at 30 ° C. at a flow rate of 50 to 60 mL / min, and the biofilm adhered in the Teflon (registered trademark) tube before and after the treatment is visually confirmed after being stained with 0.1% crystal violet. did. In the biofilm formation state, 0-10% of the biofilm adhesion of the control was marked with ◎, 10-40% with ◯, 40-80% with Δ, and 80% or more with x.
The results are shown in Table 4.
以上の結果から、本発明品のバイオフィルム除去効果は明らかである。なお、テフロン(登録商標)チューブは、内視鏡用途に使用されているものであり、当該効果より、本発明は、内視鏡用途のバイオフィルム除去効果にすぐれていることがわかる。 From the above results, the biofilm removal effect of the product of the present invention is clear. The Teflon (registered trademark) tube is used for an endoscope application, and it can be seen from the effect that the present invention is excellent in the biofilm removal effect for the endoscope application.
Claims (5)
で表わされる塩基性アミノ酸誘導体又はその塩を含有する医療機器用洗浄剤組成物水溶液に医療機器を浸漬するか、該水溶液の水流中に医療機器を置くか、又は超音波振動を与えつつ該水溶液と医療機器を接触させる、医療機器の洗浄方法。 The following general formula (1)
The medical device is immersed in an aqueous cleaning agent composition solution containing a basic amino acid derivative represented by the formula (I) or a salt thereof, or the medical device is placed in a water stream of the aqueous solution, or the aqueous solution is subjected to ultrasonic vibration. A method of cleaning medical equipment, where medical equipment is brought into contact with
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009199783A JP5466904B2 (en) | 2007-11-28 | 2009-08-31 | Cleaning method for medical equipment |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007307261 | 2007-11-28 | ||
JP2007307261 | 2007-11-28 | ||
JP2009199783A JP5466904B2 (en) | 2007-11-28 | 2009-08-31 | Cleaning method for medical equipment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008296289A Division JP4388587B2 (en) | 2007-11-28 | 2008-11-20 | Biofilm remover |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010013655A JP2010013655A (en) | 2010-01-21 |
JP5466904B2 true JP5466904B2 (en) | 2014-04-09 |
Family
ID=40919360
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008296289A Expired - Fee Related JP4388587B2 (en) | 2007-11-28 | 2008-11-20 | Biofilm remover |
JP2009199783A Expired - Fee Related JP5466904B2 (en) | 2007-11-28 | 2009-08-31 | Cleaning method for medical equipment |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008296289A Expired - Fee Related JP4388587B2 (en) | 2007-11-28 | 2008-11-20 | Biofilm remover |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP4388587B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009149858A (en) * | 2007-11-28 | 2009-07-09 | Kao Corp | Cleaning agent composition for hard surface |
JP5545870B2 (en) * | 2010-12-13 | 2014-07-09 | 花王株式会社 | Biofilm remover |
JP5670783B2 (en) * | 2011-03-07 | 2015-02-18 | 花王株式会社 | Biofilm removal method |
JP5980479B2 (en) * | 2011-03-31 | 2016-08-31 | 小林製薬株式会社 | Biofilm removal composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4872118A (en) * | 1971-12-27 | 1973-09-29 | ||
JPH0692350B2 (en) * | 1988-06-28 | 1994-11-16 | 賢治 市川 | Antibacterial substance, antibacterial resin molded product containing the same, antibacterial synthetic fiber, antibacterial paper, antibacterial paint and synthetic resin antibacterial aquarium |
US5731275A (en) * | 1994-04-05 | 1998-03-24 | Universite De Montreal | Synergistic detergent and disinfectant combinations for decontaminating biofilm-coated surfaces |
JP4051718B2 (en) * | 1996-02-06 | 2008-02-27 | 味の素株式会社 | Surfactant and cosmetic and detergent composition containing the same |
WO1997030057A1 (en) * | 1996-02-19 | 1997-08-21 | Sangi Co., Ltd. | Antibacterial amino acids, inorganic salts thereof, and process for the preparation and use thereof |
JP4055235B2 (en) * | 1998-02-27 | 2008-03-05 | 味の素株式会社 | Disinfectant composition |
US6242009B1 (en) * | 1999-04-20 | 2001-06-05 | Kareem I. Batarseh | Microbicidal formulations and methods to control microorganisms |
MXPA01013447A (en) * | 1999-06-25 | 2002-12-05 | Arch Chem Inc | Pyrithione biocides enhanced by silver, copper, or zinc ions. |
JP4972743B2 (en) * | 2005-11-04 | 2012-07-11 | 国立大学法人広島大学 | Cleaning composition and cleaning method |
-
2008
- 2008-11-20 JP JP2008296289A patent/JP4388587B2/en not_active Expired - Fee Related
-
2009
- 2009-08-31 JP JP2009199783A patent/JP5466904B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4388587B2 (en) | 2009-12-24 |
JP2009149857A (en) | 2009-07-09 |
JP2010013655A (en) | 2010-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2236594B1 (en) | Method for removing biofilms | |
JP7149072B2 (en) | Disinfectant composition containing quaternary ammonium compound | |
AU2011342791B2 (en) | Wear resistant antimicrobial compositions and methods of use | |
CN101861379A (en) | Formulations comprising antimicrobial compositions | |
JP6092850B2 (en) | Coupling agent of medium chain fatty acid and bactericidal composition | |
JP5466904B2 (en) | Cleaning method for medical equipment | |
JP2009149858A (en) | Cleaning agent composition for hard surface | |
JP2012072265A (en) | Biofilm removing agent and composition for removing biofilm | |
JP2009078987A (en) | Method for preventing formation of biofilm | |
JP2010126710A (en) | Biofilm removing agent composition | |
JP5110860B2 (en) | Biofilm control agent composition | |
JP5322400B2 (en) | Biofilm control agent composition | |
JP5209864B2 (en) | Biofilm formation inhibitor composition | |
JP5639345B2 (en) | Biofilm remover composition | |
JP5513776B2 (en) | Biofilm remover composition | |
JP5601793B2 (en) | Biofilm remover composition | |
JP2008100964A (en) | Biofilm formation inhibitor composition | |
EP4165158B1 (en) | A disinfectant and cleaning composition | |
JP2010126526A (en) | Biofilm-controlling agent composition | |
US12043820B2 (en) | Hard surface cleaning composition | |
JP5188950B2 (en) | Hard surface cleaning and sterilization method | |
JP2010126525A (en) | Method for sterilizing microorganism in biofilm | |
CA3077837A1 (en) | Hard surface cleaner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111101 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131029 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131112 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140121 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140127 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5466904 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |